Semaglutide denied as not medically necessary by Humana?

Humana's specific coverage criteria for semaglutide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denies Semaglutide on Medical-Necessity Grounds

Humana's medical-necessity denials for semaglutide typically reflect a reviewer's conclusion that the submitted documentation did not clearly establish that the patient meets the clinical criteria set out in Humana's coverage policy for this drug class. These denials are common at initial review and are frequently overturned on appeal when the right documentation is assembled.

## Why This Denial Is Appealable

A medical-necessity determination is not a final verdict — it is a coverage decision based on whatever documentation the plan had at the time of review. Federal law gives you the right to challenge it. Under the ACA (Section 2719) and, for employer plans, ERISA Section 503, every insured person has the right to a full-and-fair internal appeal followed by an independent external review conducted by a reviewer with no financial relationship to the plan. The external-review window is generally open for roughly four months after you receive the denial notice. If your condition is urgent, you may request an expedited review, which must be decided within 72 hours.

## The Appeal Process

1. Request the full denial letter — it must state the specific criteria Humana found unmet and cite the clinical review guideline used. 2. File the internal appeal — typically within 180 days of the denial; confirm the exact deadline on your Explanation of Benefits. 3. Request an external review — if the internal appeal is denied, you may escalate to an Independent Review Organization (IRO) immediately.

## Documentation to Gather

• Diagnosis confirmation: chart notes, lab results, or imaging that establish the underlying diagnosis (obesity, Type 2 diabetes, or cardiovascular disease, depending on the indicated use).
• Prior-treatment history: names, dates, and documented outcomes of any prior medications or interventions the policy requires you to have tried.
• Clinical severity: measurable findings from the medical record — weight trend, metabolic markers, comorbidities — that establish why treatment is medically necessary now.
• Prescriber medical-necessity letter: a detailed letter from your physician explaining the clinical rationale, referencing the applicable guideline organization (such as the Obesity Medicine Association, ADA Standards of Care, or ACC/AHA cardiovascular guidelines) without relying solely on manufacturer materials.

## Criteria-Mapping Structure

Obtain a copy of Humana's current published coverage policy for this drug and the FDA-approved prescribing label. List every requirement Humana states. For each requirement, document the exact chart entry, date, and provider note that satisfies it. A side-by-side table — "Policy Criterion / Chart Evidence / Date" — is the most persuasive format for an appeal reviewer. Do not rely on general assertions; match each criterion to a specific, dated medical record entry.

This structured approach addresses the most common reason internal appeals fail: the absence of explicit criterion-by-criterion documentation rather than any underlying clinical deficiency.